Ilex South Africa

Diamond, Congress Programme Book and Delegate Bag Sponsor
Ilex South Africa was established in 1992 as a wholly owned subsidiary of Ilex Medical LTD. Today Ilex South Africa’s one of the major suppliers of IVD products with a strong emphasis on blood banks, critical care products, as well as laboratory information systems (LIS).

The company’s success is based on providing services and products of the highest quality within the various niche markets.

Within the blood transfusion market Ilex is the solution provider for the prevention of Transfusion Transmissible Infections (TTIs) with:

  • Improved nucleic acid testing (NAT) with blood screening products featuring automation, comprehensive assay tests and simplified reporting. Grifols PROCLEIX Panther, a system that offers an automated state-of-the-art nucleic acid testing (NAT), for blood screening of various parameters. The reagents on the Panther, PROCLEIX ULTRIO Elite assay, is intended to deliver all the benefits of detecting HIV-1, HIV-2, HCV and HBV. NAT testing detects viral RNA and DNA during every stage of infection and replication.

    With the Panther, the customer has the flexibility to test donor samples with minimal hands-on time, increased efficiency and throughput and reducing turn-around-time. The Panther’s compact footprint has the highest test throughput per square meter of any other NAT system on the market.
    The Panther system brings to the lab full automated processing of donor samples, high throughput, built-in process control for quality assurance, full confidence in result output and information on demand. Once the technologist starts the run, they are free to leave the system and move on to other work. They are able to check on progress and estimate completion time at any point.

    The Panther is the fully automated systems that revolutionises NAT for peak productivity in the lab.

  • The Cerus INTERCEPT pathogen inactivation a solution that is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood.

    The INTERCEPT Blood System has significantly enhanced blood safety at more than 100 blood centres worldwide. INTERCEPT offers proven pathogen inactivation of >5 logs for a broad range of enveloped and non-enveloped viruses, bacteria and protozoa, as well as leukocytes.

    Pathogen inactivation selectively damages genetic material. By preventing the replication of DNA and RNA, which is needed by contaminating agents (pathogens) to transmit infection, pathogen inactivation neutralises a broad spectrum of viruses, bacteria and parasites, as well as potentially harmful white blood cells, without interfering with the therapeutic effect of blood components.

Ilex also has a comprehensive Laboratory Information management system, elab. It is capable of managing a wide range of laboratory needs, such as interfacing with all clinical analyzers, host machines and ERP systems available today. Intuitive user interfaces and powerful analytical features assist the lab technician and clinical expert in making the right decisions. Access control and audit trails keep your data secure and help you conform to recent legislative guidelines concerning data integrity and patient security.

Contact Ilex for more information on any of the products listed above.
Tel: +27 11 808 4004
Fax: +27 11 804 1120
Visit our website